348 related articles for article (PubMed ID: 23619376)
1. Orthotopic and heterotopic tracheal transplantation model in studying obliterative bronchiolitis.
Fan K; Qiao XW; Nie J; Yuan L; Guo HZ; Zheng ZK; Li JS; Wang JJ; Jiang K
Transpl Immunol; 2013 Jun; 28(4):170-5. PubMed ID: 23619376
[TBL] [Abstract][Full Text] [Related]
2. Apoptosis of the Tracheal Epithelium Can Increase the Number of Recipient Bone Marrow-Derived Myofibroblasts in Allografts and Exacerbate Obliterative Bronchiolitis After Tracheal Transplantation in Mice.
Wang C; Xia T; Jiang K; Qiao X; Zhang X; Li J; Wang J; Nie J
Transplantation; 2016 Sep; 100(9):1880-8. PubMed ID: 27163540
[TBL] [Abstract][Full Text] [Related]
3. [Establishment of obliterative bronchiolitis in allo-trachea transplant model of rat and detection of its pathogenesis preliminarily].
Qi Z; Yang DY; Wang R; Wang SZ; Ping YM
Zhonghua Wai Ke Za Zhi; 2007 Feb; 45(4):262-6. PubMed ID: 17502025
[TBL] [Abstract][Full Text] [Related]
4. Suppression of the obliteration process by ventilation in a mouse orthotopic tracheal transplantation model.
Chen C; Zhang YZ; Zheng H; Xu BB; Gao W
Transplantation; 2009 Jun; 87(12):1762-8. PubMed ID: 19543051
[TBL] [Abstract][Full Text] [Related]
5. Role of airway epithelial injury in murine orthotopic tracheal allograft rejection.
Kuo E; Bharat A; Shih J; Street T; Norris J; Liu W; Parks W; Walter M; Patterson GA; Mohanakumar T
Ann Thorac Surg; 2006 Oct; 82(4):1226-33. PubMed ID: 16996912
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of obliterative airway disease development following heterotopic murine tracheal transplantation by costimulatory molecule blockade using anti-CD40 ligand alone or in combination with donor bone marrow.
Fernández FG; McKane B; Marshbank S; Patterson GA; Mohanakumar T
J Heart Lung Transplant; 2005 Jul; 24(7 Suppl):S232-8. PubMed ID: 15993779
[TBL] [Abstract][Full Text] [Related]
7. Reproduction of the obliterative bronchiolitis lesion after heterotopic transplantation of mouse airways.
Hertz MI; Jessurun J; King MB; Savik SK; Murray JJ
Am J Pathol; 1993 Jun; 142(6):1945-51. PubMed ID: 8506960
[TBL] [Abstract][Full Text] [Related]
8. Tacrolimus treatment effectively inhibits progression of obliterative airway disease even at later stages of disease development.
Hollmén M; Tikkanen JM; Nykänen AI; Koskinen PK; Lemström KB
J Heart Lung Transplant; 2008 Aug; 27(8):856-64. PubMed ID: 18656798
[TBL] [Abstract][Full Text] [Related]
9. Enhancement of obliterative airway disease in rat tracheal allografts infected with recombinant rat cytomegalovirus.
Reichenspurner H; Soni V; Nitschke M; Berry GJ; Brazelton T; Shorthouse R; Huang X; Boname J; Girgis R; Raitz BA; Mocarski E; Sandford G; Morris RE
J Heart Lung Transplant; 1998 May; 17(5):439-51. PubMed ID: 9628562
[TBL] [Abstract][Full Text] [Related]
10. Immune cells in a mouse airway model of obliterative bronchiolitis.
Neuringer IP; Mannon RB; Coffman TM; Parsons M; Burns K; Yankaskas JR; Aris RM
Am J Respir Cell Mol Biol; 1998 Sep; 19(3):379-86. PubMed ID: 9730865
[TBL] [Abstract][Full Text] [Related]
11. Rejection of tracheal allograft by intrapulmonary lymphoid neogenesis in the absence of secondary lymphoid organs.
Wagnetz D; Sato M; Hirayama S; Matsuda Y; Juvet SC; Yeung JC; Guan Z; Zhang L; Liu M; Waddell TK; Keshavjee S
Transplantation; 2012 Jun; 93(12):1212-20. PubMed ID: 23318304
[TBL] [Abstract][Full Text] [Related]
12. Tissue inhibitor of metalloproteinase-1 deficiency abrogates obliterative airway disease after heterotopic tracheal transplantation.
Chen P; Farivar AS; Mulligan MS; Madtes DK
Am J Respir Cell Mol Biol; 2006 Apr; 34(4):464-72. PubMed ID: 16388023
[TBL] [Abstract][Full Text] [Related]
13. Role of nitric oxide in experimental obliterative bronchiolitis (chronic rejection) in the rat.
Kallio EA; Koskinen PK; Aavik E; Vaali K; Lemstöm KB
J Clin Invest; 1997 Dec; 100(12):2984-94. PubMed ID: 9399944
[TBL] [Abstract][Full Text] [Related]
14. Different kinetics of obliterative airway disease development in heterotopic murine tracheal allografts induced by CD4+ and CD8+ T cells.
Higuchi T; Jaramillo A; Kaleem Z; Patterson GA; Mohanakumar T
Transplantation; 2002 Sep; 74(5):646-51. PubMed ID: 12352880
[TBL] [Abstract][Full Text] [Related]
15. Donor antigen-presenting cells are important in the development of obliterative airway disease.
Szeto WY; Krasinskas AM; Kreisel D; Popma SH; Rosengard BR
J Thorac Cardiovasc Surg; 2000 Dec; 120(6):1070-7. PubMed ID: 11088028
[TBL] [Abstract][Full Text] [Related]
16. Obliterative airway disease after heterotopic tracheal xenotransplantation: pathogenesis and prevention using new immunosuppressive agents.
Reichenspurner H; Soni V; Nitschke M; Berry GJ; Brazelton TR; Shorthouse R; Huang X; Reitz BA; Morris RE
Transplantation; 1997 Aug; 64(3):373-83. PubMed ID: 9275099
[TBL] [Abstract][Full Text] [Related]
17. The effects of pretreatment with donor antigen and immunosuppressive agents on fully allogenic tracheal graft.
Suemitsu R; Yoshino I; Shoji F; Yamaguchi M; Tomita Y; Maehara Y
J Surg Res; 2004 Nov; 122(1):8-13. PubMed ID: 15522308
[TBL] [Abstract][Full Text] [Related]
18. Small animal models of experimental obliterative bronchiolitis.
Jungraithmayr W; Jang JH; Schrepfer S; Inci I; Weder W
Am J Respir Cell Mol Biol; 2013 Jun; 48(6):675-84. PubMed ID: 23392572
[TBL] [Abstract][Full Text] [Related]
19. A novel MyD88 inhibitor attenuates allograft rejection after heterotopic tracheal transplantation in mice.
Yang M; Chen G; Zhang X; Ding Z; Miao Y; Yang Y; Chen ZK; Jiang F; Chang S; Zhou P
Transpl Immunol; 2019 Apr; 53():1-6. PubMed ID: 30472390
[TBL] [Abstract][Full Text] [Related]
20. FK506 combined with GM6001 prevents tracheal obliteration in a mouse model of heterotopic tracheal transplantation.
Li Y; Shu P; Tang L; Yang X; Fan J; Zhang X
Transpl Immunol; 2019 Dec; 57():101244. PubMed ID: 31526865
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
